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ABSTRACT  
 
Background  
Lower respiratory tract infections (LRTI) are a leading cause of mortality and morbidity in all age-
groups. In Zimbabwe, few epidemiological studies have mapped the aetiology and distribution of 
LRTIs as well as risk factors for LRTI-related mortality. Understanding the epidemiological 
profile of LRTIs is important in many ways. The aim of this study was to describe the aetiology 
and clinical aspects of LRTIs in patients reporting to a referral hospital in Harare, Zimbabwe. 
 
Methods  
The study was a cross-sectional survey of 103 patients who had microbiology reports associated 
with a clinical diagnosis of LRTI at the Harare Central Hospital during 2014.  The records showed 
bacterial cultures were done on the majority of adult samples while most children samples were 
sent for viral testing. The record books had a lot of missing data. 
 
Results 
Enterobacteriaceae were the most frequently isolated organisms in the laboratory (11.7%). 
Pneumonia (45.6%) and influenza (44%) were the most prevalent acute respiratory illnesses in 
the study. HIV infection and underlying cardiovascular disease were significant risk factors for 
mortality with odds ratio of 4.78, p= 0.016 and 4.42, p= 0.0028 respectively. 
 
Conclusion  
Enterobacteriaceae were the most common isolates from patients with LRTI; with respiratory 
syncytial virus associated LRTIs being most common among children under 5. Being HIV 
positive and having cardiovascular disease is a strong predictor of death in patients with LRTIs. 
The amount of missing data also emphasised the importance of robust data management systems 
in hospitals to better inform epidemiological studies. 
 
Keywords:  lower respiratory tract infections, epidemiological profile, aetiology, Zimbabwe 
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INTRODUCTION 
Lower respiratory tract infections (LRTI) are regarded as one of the leading causes of morbidity 
and mortality for all age-groups globally with an estimated 2.7 million deaths attributable to them 
in 2013 (1). The global incidence ranges from 40 to 50 per 1000 (2, 3) and infections of the 
respiratory tract are responsible for 4.4% of hospital admissions and 6.6% of primary care 
consultations (3). In Sub-Saharan Africa, the incidence is 44 episodes per 100 child years with 7 
to 13% of the episodes warranting hospitalisation (4).  The aetiology and symptomatology of 
respiratory diseases varies with age, gender, season, the type of population at risk and other factors. 
(5). 
 
Aetiological agents implicated in the pathogenesis of LRTIs include viruses like respiratory 
syncytial virus, adenoviruses, influenza virus, human metapneumovirus and para-influenza virus 
(6) and bacteria such as Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus 
influenzae, Moraxella catarrhalis, Escherichia coli, Salmonella species Mycoplasma 
pneumoniae, and Chlamydophila pneumoniae (7). The HIV epidemic has led to the emergence 
of other aetiological agents which were previously not considered pathogenic like Pneumocystis 
jirovecii, while there is lack of data on the role other atypical pathogens like Mycoplasma and 
Legionella in LRTI in Africa, mainly due to difficulties in confirming the diagnosis. In 
immunocompromised patients and especially in children, these pathogens have been found in 
polymicrobial pneumonia (8). Furthermore the role of tuberculosis as an aetiological agent of 
LRTI in HIV-infected patients should be emphasised as Mycobacterium tuberculosis infection 
induces the activation of immune system cells which favour viral replication which may lead to 
development of opportunistic infection including LRTIs (9). 
 
Therapy for LRTIs in the community is usually empirical; however there is growing concern about 
antimicrobial resistance that has complicated the selection of suitable antibiotics (10). 
Pneumococcal resistance to penicillin has been widely documented in Africa and the rest of the 
world (3, 11). Resistance to co-trimoxazole and chloramphenicol has also been described (3). 
According to the local guidelines using the Essential Drug List of Zimbabwe 2011 (EDLIZ), the 
choice of therapy is influenced by HIV status. However if tuberculosis and P. jirovecii pneumonia 
has been ruled out then amoxylin is the first drug of choice but in the case allergy to penicillin then 
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erythromycin can be given to patients with pneumonia and severe LRTIs. However the aetiological 
agent of pneumonia influence the drug of choice (12). An understanding of antimicrobial 
resistance patterns would better inform clinical decisions around antibiotic treatment. 
 
In Zimbabwe and other developing countries where lower respiratory tract infections are one of 
the leading causes of morbidity and mortality, clinical management is often more difficult. There 
is a lack of technical expertise and resources required for etiological identification and antibiotic 
susceptibility testing to enable appropriate antibiotic therapy. In addition, little is known about the 
etiological distribution of pathogens causing LRTIs in Zimbabwe with the last study done in 
children more than 2 decades ago by Nathoo et.al (1993) (13). This study documented clinical and 
socio-demographic features and also identified risk factors for mortality in children hospitalized 
with acute lower respiratory tract infection. Malnutrition, severe LRTI, age of 1 to 6 months, 
concurrent diarrhoea, duration of cough greater than or equal to 14 days and previous history of 
admission for LRTI were significant risk factors for mortality in LRTI. The impact of HIV 
infection on mortality in children with LRTIs was found to be of major concern in Zimbabwe. The 
Zimbabwe Global Burden of Disease Study in 2010 showed that LRTIs cause 11.7% of premature 
deaths, and are second to HIV (29%) in terms of the number of years of life lost (YLLs) due to 
premature death in Zimbabwe (14). 
 
The aim of the current study was to first, describe the aetiology and clinical aspects of acute 
respiratory illnesses, and second, investigate the risk factors for LRTI-related mortality in patients 
reporting to a referral hospital in Harare, Zimbabwe.  
  
METHODS 
 
Study design, setting and population 
A cross-sectional survey using routinely collected patient data was conducted at Harare Central 
Hospital, which is the second largest tertiary care hospital in Harare, the capital city of Zimbabwe. 
Harare Central Hospital covers over half of Harare’s population and patients presenting to the 
hospital could thus be considered representative of the general population of Harare. The satellite 
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clinics mostly refers patients to the Harare Central Hospital due to their close proximity to majority 
of high density suburbs as well as availability of laboratory facilities which are affordable. The 
patient population consisted of patients of all ages who had a respiratory tract sample submitted to 
the microbiology laboratory and who had signs and symptoms of LRTI from 1 January to 31 
December 2014.  
  
Study procedure 
 
Laboratory methods and data 
 
PTM, [Principal Investigator (PI)] used data recorded in the microbiology laboratory record 
books to identify patients who had the following specimens submitted: bronchial lavage, 
nasopharyngeal aspirate and sputum. A unique study identification number was assigned to each 
participant for anonymity and to ensure patient data confidentiality. Data were extracted from the 
laboratory record books on age, gender, clinical diagnosis prior to microbiology, test date, type 
of specimen collected, bacteriology and/or virology results, and antibiotic sensitivity results.  
According to the laboratory protocol, all respiratory samples were examined by Gram 
staining (for bacteria and yeasts) and  KOH preparation or Periodic acid-Schiff-stained smears 
for fungal element detection and cultured for common bacterial respiratory pathogens on  5% 
human blood agar, MacConkey agar (for isolation and differentiation of gram negative bacilli), 
and chocolate agar (for Haemophilus and Neisseria species). Samples were also sent for 
virological testing if clinically requested and the laboratories used polymerase chain reaction 
(PCR) for identification. For tuberculosis detection, Ziehl-Neelsen stain was used first followed 
by a confirmation with Lowestein-Jensen culture medium. The records did not indicate if any 
adult samples were referred for viral detection.  
 
Clinical data 
The unique hospital number assigned to the patient on initial admission was used to link the 
medical records of the patients. Data were obtained only from clinical management records of 
patients of all ages who had reported with some but not limited to all clinical signs and 
symptoms of lower respiratory tract illness which include cough, dyspnoea, tachypnoea, chest 
pain, fever, wheezing and abnormalities on auscultation suggesting an LRTI and diagnosed by 
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the physician with an LRTI during the study period. The following data was retrieved from the 
medical records: route of referral, probable diagnosis, date of onset of clinical symptoms/illness 
and chest X-ray results. Information, if available, on comorbidities such human 
immunodeficiency virus (HIV) infection, laboratory confirmed tuberculosis (TB) (current or 
previously diagnosed), asthma, chronic obstructive pulmonary disease, diabetes, underlying 
malignancy and pregnancy was also collected. Furthermore, data on treatment and management 
of the acute respiratory tract illness such as antibiotics prescribed (by self or clinician), antivirals 
(peramivir, oseltamivir) prescribed (by self or clinician), inhaled corticosteroids, intravenous 
corticosteroids and hospitalisation, were extracted. Patient outcomes were recorded in terms of 
length of stay in hospital and whether the patient was discharged or deceased. Ambiguous or 
unclear records were clarified by the PI with the practitioner who recorded the details, or another 
experienced practitioner. For data entry validation, the PI and another independent assessor 
rechecked a ten percent sample of the data following completion of data entry to identify any 
data entry errors. 
 
Data Management and Statistical Analysis  
Data were entered into a Microsoft excel spreadsheet and stored in a password protected folder. 
All statistical analyses were carried out using Stata version 13 (Stata Corp, College Station, Texas, 
United States of America). Characteristics of the study sample were analysed using descriptive 
statistics with results expressed as numbers and percentages. The aetiology of LRTIs was 
described for the overall sample using percentages and distribution by age-group and gender was 
assessed. Differences in distribution of organisms by gender and age group were assessed using 
Fisher’s exact test. Logistic regression was used to identify predictors of LRTI-related mortality. 
A sensitivity analysis of predictors of LRTI-related mortality was also conducted after the 
unadjusted logistic regression to evaluate if there was any impact caused by the missing values 
and in this case all the missing values were recoded as 'no'. However in every other analysis done 
all missing data was coded as missing and reported.  
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Ethical approval 
Ethical approval and waiver of informed consent was obtained from the Human Health Research 
Ethics Committee of the University of Stellenbosch (S15/07/148) and Harare Central Hospital 
Ethics committee (HCHEC 160715/54). The methods followed in obtaining data were in 
accordance with the ethical standards of the committees that gave ethical clearance, and the 
Helsinki Declaration. 
 
RESULTS 
The analysis included 103 patients of whom 53% were male. Twenty children below the age of 
15 were included in the study with 14 being under the age of 2 and of those 6 being neonates. 
The median age was 31.5 years with the age ranging from 0 years to 86 years. The mean age was 
21.7 years (Standard Deviation, (SD) 14.1). 76.7% of patients were hospitalised and the mean 
length of stay in hospital was 4.7 days (interquartile range 2-6 days). Approximately 65% of 
hospitalised patients were discharged alive while 13.6% died in hospital and in 21.4 % the 
outcome was unknown. Table 1 summarises the study sample characteristics. 
 
Table 1: Characteristics of the study sample (n=103) 
 
Characteristic Number (%) 
Sex 
 Male 
 Female 
 Missing 
 
46 (44.7) 
55 (53.4)  
2   (1.9)  
Referral 
 Clinician 
 Self-referral 
 Other 
 
62 (60.2)        
37 (35.9)    
 4  (3.9) 
Specimen  
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  Throat swab 
  Bronchial lavage 
  Nasopharyngeal aspirate 
  Sputum 
1   (1.0) 
32 (31.1) 
31 (30.1) 
39 (37.8) 
  
Chest X-ray done  
  No 
  Yes 
  Unknown 
 
37 (35.9) 
61 (59.2) 
5   (4.9) 
Chest X-ray Results 
   Normal 
   Abnormal 
   CXR done but report not known 
 
11 (18.0) 
46 (75.4) 
 4  (6.6) 
HIV 
 No 
 Yes 
 Unknown/missing 
 
63 (61.2) 
24 (23.3) 
16 (15.5) 
TB (laboratory confirmed) 
 No 
 Yes 
 Unknown/missing 
 
68 (66.0) 
15 (14.6) 
20 (19.4) 
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Asthma 
 No 
 Yes 
 Unknown/missing 
 
70 (68.0) 
 7  (6.8) 
26 (25.2) 
COPD 
 No 
 Yes 
 Unknown/missing 
 
63 (61.2) 
3   (2.9) 
37 (35.9) 
Heart disease 
 No 
 Yes 
 Unknown/missing 
 
57 (55.3) 
28 (27.2) 
18 (17.5) 
Diabetes 
 No 
 Yes 
 Unknown/missing 
 
74 (71.8) 
12 (11.7) 
17 (16.5) 
Cancer 
 No 
 Yes 
 Unknown/missing 
 
17 (69.5) 
13 (12.8) 
18 (17.7) 
Pregnancy 
 No 
 
92 (89.3) 
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 Yes 
 Unknown/missing 
4 (3.9) 
7 (6.8) 
Hospitalisation in the last 12 months 
 No 
 Yes 
 Unknown/missing 
 
21 (20.4) 
79 (76.7) 
3 (2.9) 
Discharged 
 Discharged alive 
 Died in hospital 
 Unknown/missing/not applicable 
 
51  (64.1) 
11  (13.6) 
17  (22.3) 
 
 Pathogen Spectrum 
Potential pathogens were only isolated in 31/103 samples (30.1%); the remainder of the 
specimens were reported as either normal flora or no growth. A small proportion of samples 
were reported as Streptococcus viridans (6, 5.9 %) and Candida species (3, 0.97%); since these 
organisms are not generally regarded as likely causes of LRTI, they were also classified as 
normal flora. No patients had more than one organism isolated according to the records.The 
spectrum of pathogens isolated is shown in Fig 1. The most commonly isolated organisms were 
lactose fermenting Enterobacteriaceae (11.7%). Standard practice in the local microbiology 
laboratory is not to identify these organisms further, due to resource constraints. Streptococcus 
pneumoniae, Staphylococcus aureus and Group D Streptococcus were also isolated (Fig.1). 
Fifteen out of 20 children samples were sent for virology with 8 being found positive for RSV. 
Table 2 shows the distribution of the isolates relating to the sample processed. 
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Fig.1 Organisms Isolated (y axis is expressed as a % of all samples) 
 
 
 
 
Table 2. Distribution of the isolates relating to the sample processed 
 
 Group A 
Streptococcus 
Group D 
Streptococcus 
LFC NLF Staphylococcus 
aureus  
Streptococcus 
agalactiae 
Streptococcus 
pneumonia 
Yeast 
other 
than 
candida 
Specimen         
Throat 
swab 
0 0 1 0 0 0 0 0 
Bronchial 
Lavage 
1 2 4 0 0 0 1 0 
Nasopharyngeal 
aspirate 
0 0 3 0 1 0 0 0 
Sputum 0 0 4 1 1 1 2 2 
         
LFC – Lactose Fermenting Colonies 
NLF - Non Lactose Fermenting Colonies 
 
 
0
2
4
6
8
10
12
14
%
Organism
Stellenbosch University  https://scholar.sun.ac.za
16 
 
Distribution of microorganisms by age and gender 
There was no statistically significant difference in isolation rates by gender and age after 
conducting the Fisher’s exact test (p = 0.25 and p = 0.33 respectively). If RSV is included, most 
organisms were isolated in children under 15 years, especially in the age group 6 to 15 years. The 
8.7% period prevalence of RSV was all in children under 5 years of age. 
 
Clinical Diagnoses associated with LRTI symptoms 
 The three most prevalent lower respiratory tract infections listed as probable diagnoses were 
pneumonia (45.9%), influenza (44%) and pulmonary tuberculosis (32%).  (Table 3). 
 
Table 3. Clinical Diagnoses associated with LRTI symptoms 
 
 
Clinical Diagnoses  Number (%) 
CCF 1 (1.0) 
Influenza 43 (43.9) 
Bronchitis 5 (5.1) 
Pneumonia 45 (45.9) 
Pleural effusion 17 (17.3) 
Lung cancer 3 (3.1) 
Pulmonary tuberculosis 31 (31.6) 
RSV  8 (8.2) 
 
Antimicrobial Susceptibility Profile 
Antibiotic resistance patterns could not be analysed due to the fact that antibiotic susceptibility 
tests were only conducted on 28 isolates out of the 31 potential pathogens isolated, and there was 
a marked lack of consistency in the panels of antibiotics tested. No antimicrobial susceptibility 
tests were conducted for yeasts that were isolated.  
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Prescribing practices for LRTI  
Antibiotics were prescribed to most patients and 92.2% of all participants had either self-
prescribed an antibiotic or antibiotics were prescribed by the clinician. However, details about 
which specific agents were self-prescribed were not available in most of the record books. 
Intravenous corticosteroids were prescribed to 35.9% of hospitalised patients. Antivirals 
(peramivir, oseltamivir) were prescribed in 36.9% patients (Table 4). 
 
Table 4. Drugs prescribed for patients with LRTI  
 
 Yes (%) No (%) Unknown 
Antibiotics 95 (92.2) 3 (2.9) 5 (4.9) 
Antivirals 38 (36.9)  60 (58.2) 5 (4.9) 
Inhaled steroids 25 (24.3) 72 (69.9) 6 (5.8) 
Intravenous steroids 37 (35.9) 61 (59.2) 5 (4.9) 
 
Predictors of LRTI-related Mortality 
Univariate logistic regression analysis was conducted and the results are shown in Table 5. A 
significant association was found between being HIV positive and mortality [crude odds ratio 
(OR): 4.78 (95% CI: (1.34-16.98), p= 0.016] and heart disease was also a significant predictor of 
mortality [crude OR 4.42, (95% CI: (1.17–16.67) p= 0.0028]. No significant relationship was 
found between laboratory-confirmed TB and death (Table 4). Use of antiviral agents and 
intravenous steroids was significantly associated with mortality, [crude OR 7.74, (95% CI: (1.99-
30.05) p=0.003] and (crude OR 3.6, (95% CI: (1.10- 11.76) p=0.034] respectively. It was not 
possible to conduct a multivariable analysis because of the small sample size. 
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Table 5: Predictors of mortality (unadjusted logistic regression results) 
Independent 
predictor 
variable 
Non-survivors 
Number (%) 
Survivors  
Number 
(%) 
Unadjusted OR (95% 
CI) 
P 
value 
Patient medical history (comorbidities) 
HIV 
No 
Yes 
Missing 
   
 
58 (65.2) 
17 (19.1) 
14 (15.7) 
 
5 (35.7) 
7 (50.0) 
2 (14.3) 
 
1 (reference group) 
4.78 (1.34-16.98) 
- 
 
 
0.016 
TB 
No  
Yes 
Missing 
 
59 (66.3) 
12 (13.5) 
18 (20.22) 
 
9 (66.0) 
3 (21.4) 
2 (14.29) 
 
1 (reference group) 
1.64 (0.39 -6.96) 
 
 
0.503 
Heart disease 
No  
Yes 
Missing 
  
53 (59.4) 
21 (23.6) 
15 (16.9) 
 
4 (28.6) 
7 (50.0) 
3 (21.4) 
 
 
1 (reference group) 
4.42 (1.17–16.67) 
 
 
0.028 
Patient treatment characteristics 
Antivirals  
  No 
  Yes 
  Missing 
 
57 (64.0) 
27 (30.3) 
5 (5.6) 
 
3 (21.4) 
11 (78.6) 
0 (0.0) 
 
1 (reference group) 
7.74 (1.99-30.05) 
- 
 
 
 
0.003 
IV steroids     
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  No 
  Yes 
  Missing 
56 (62.9) 
28 (31.5) 
5   (5.62) 
5 (35.7) 
9 (64.3) 
0 (0.0) 
1 (reference group) 
3.6 (1.10- 11.76) 
- 
 
0.034 
Inhaled 
steroids 
  No 
  Yes 
  Missing 
 
 
64 (71.9) 
20 (22.5) 
5  (5.6) 
 
 
8 (57.1) 
5 (35.7) 
1 (7.1) 
 
 
1 (reference group) 
2 (0.59-6.81) 
- 
 
 
0.267 
Antibiotics 
  No 
  Yes 
  Missing 
 
0 (0.0) 
14 (100.0) 
0 (0.0) 
 
3 (3.37) 
81 (91.0) 
5 (5.62) 
 
-* 
 
*Unable to calculate OR due to insufficient data  
OR= odds ratio; CI= confidence interval 
 
The results of sensitivity analysis of predictors of LRTI-related mortality were almost similar to 
those of the unadjusted logistic regression with the exception of TB where the p value was now 
statistically significant. (Appendix 1) 
 
DISCUSSION 
This study provides an insight into the epidemiology of lower respiratory tract infections in Harare, 
Zimbabwe, despite the small sample size.   
 
Pathogen Spectrum 
The commonly isolated bacteria were lactose fermenting coliforms at 11.7%. Where bacteria 
could be differentiated, they mainly comprised Escherichia coli and Klebsiella. However, in this 
study they were put under one umbrella because most of the bacteria could not be differentiated 
to species level due to shortage of reagents at the laboratory. Nevertheless, this finding was 
Stellenbosch University  https://scholar.sun.ac.za
20 
 
consistent with a study in Nigeria where Klebsiella pneumoniae was the most common cause of 
LRTIs (38%) (3). Conversely, S. pneumoniae and Pseudomonas aeruginosa were the most 
frequently isolated pathogens from respiratory samples in a study in Nepal (2). Gram positive 
bacteria were also isolated in this study though in small numbers, similar to the findings from 
Nigeria and Nepal (2, 3).  All the respiratory syncytial viruses were detected in children and this 
is a common causative pathogen of LRTIs in children as shown in various studies (2, 15, 
16).However this finding may have been affected by the circumstances that no adult samples 
were sent for virological tests.  No testing was performed for atypical pathogens like 
Mycoplasma and Legionella as well as Pneumocystis jirovecii and we do not know how common 
these organisms may have been. This is in line with other studies which attribute this to either 
appropriate tests not being done or the organisms being totally missed (17). Furthermore many 
studies have shown some LRTIs being caused by more than 1 isolate but which was a different 
case in our study. (18, 19). This probably more of a reflection on the quality of the laboratory 
and the tests available than necessarily a true reflection of the incidence of combined infection. 
 
Prevalence of LRTIs 
Of all patients included in the study, pneumonia was the most common LRTI diagnosed in patients 
with a prevalence of 45.9% and this was consistent with a study involving autopsies from all over 
Africa (20). RSV associated LRTI was found only in children under 5, which is in keeping with a 
systematic review of RSV which showed that RSV was mainly found in children (16). This was 
different from a study done in Kenya where influenza was the most common LRTI in children 
(15). Most of the influenza was diagnosed during the winter season in Zimbabwe, which is a 
common seasonal pattern due to the cold. However the influenza was clinically diagnosed because 
of absence of formal testing in the study setting; hence, the difference in the two studies. 
  
Predictors of Mortality 
HIV positive status was a strong predictor of mortality [crude odds ratio (OR) 4.78, p 0.016)] and 
has been reported in earlier studies (21, 22). Another comorbidity, heart disease was as also a 
strong predictor of mortality in LRTI; and the literature suggests that underlying illnesses in 
general are strong predictors of death (23). No significant relationship was found between a 
diagnosis of TB and LRTI-related death in this study, but this may have been affected by the way 
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TB was diagnosed in the setting. Most TB is diagnosed by smear microscopy which has low 
sensitivity and therefore might miss some cases. However, the GeneXpert MTB/Rif (Cepheid) has 
been introduced to the country and is being rolled out; this may improve the laboratory diagnosis 
of TB. Although Isonaziad Preventive Therapy (IPT) with antitetroviral treatment has been widely 
documented to be very effective in reducing the risk of tuberculosis in HIV patient, but the data 
could not be collected in this study. 
 
Limitations  
The study took place at one referral hospital in Harare province, which is an urban area, and 
therefore the findings may not be generalizable to other provinces, especially rural areas in which 
the environment and other risk factors may be vastly different. The data used were from record 
books and data recording was prone to transcription errors. The major limitation was missing data 
which may have affected the mapping of the respiratory illness and led to under- or overestimation 
of results. The issue of sparse data regarding respiratory illnesses and other diseases in general is 
common in the Sub Saharan Africa despite recognition of respiratory illnesses being regarded as 
one of the leading causes of death in that region (24). Data were considered for a single year so it 
might not be a true reflection of the status quo and consequently, a 5 or 10 year analysis would 
better capture the actual epidemiological trends; nevertheless, this study provides an important 
preliminary analysis that could be used as a trigger to strengthen data recording and plan future 
epidemiological studies. This study used microbiological reports from the lab and clinical records 
from the wards to identify patients with LRTIs; however, a cross-sectional study involving 
recruitment of patients may be more informative than a retrospective record review. Antimicrobial 
susceptibility trends could not be established due to missing data and lack of required resources 
for these tests in the laboratory; this is a major setback in establishing drug resistance patterns. 
Unavailability of reagents and skilled labour led to the isolated organisms not being differentiated 
to species level and this limited the amount of information available. Furthermore, atypical 
pathogens like Mycoplsama, and Legionella as well as other pathogens like Pneumocystis jirovecii 
could not be isolated due to these constraints leading to a huge gap in the epidemiology of the 
pathogen spectrum causing lower respiratory tract infections. Records for most patients who 
reported to the hospital but were not admitted are not kept by the hospital, therefore contributing 
to missing data and leading to the small sample size in this study. 
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Recommendations 
The hospital information management systems need a major overhaul as there was a significant 
amount of missing data. If possible, the hospital should consider moving to a computer-aided 
electronic data recording system that can easily link all patient records.  There is also a need to 
educate staff on the importance of record keeping and maintenance. Provision of reagents and 
skilled labour is of paramount importance to improve isolation of pathogens, to enable the 
identification of bacteria to species level, and to perform consistent antibiotic susceptibility 
testing. Resources should be allocated to detecting viruses causing LRTIs as most of the 
specimens were being sent for microbiology and with only a few samples from children being 
sent to virology. Although setting up a virology laboratory is expensive but this can be a long 
term goal for the hospitals as virology is an important aspect of pathogen detection. With this 
data, hospitals can establish specific treatment regimens, based on prevalence, pathogen 
continuum and antibiotic susceptibility patterns over time. 
 
Conclusion 
Enterobacteriaceae are the most commonly isolated organisms from patients with lower 
respiratory tract infection, and respiratory syncytial virus associated LRTIs was most common 
among children under 5. Being HIV positive is a strong predictor of death in patients with 
LRTIs. Improved data management, including the systematic collection, consolidation and 
evaluation of morbidity and mortality reports and other relevant data, is needed in hospitals to 
enable a better understanding of the epidemiology of LRTIs and other diseases.  
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Appendix 1: Sensitivity analysis results of LRTI-related mortality 
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Independent 
predictor 
variable 
Non-survivors 
Number (%) 
Survivors  
Number 
(%) 
Unadjusted OR (95% 
CI) 
P 
value 
Patient medical history (comorbidities) 
HIV 
No 
Yes 
 
72 (80.9) 
17 (19.1) 
 
7 (50.0) 
7 (50.0) 
 
1 (reference group) 
4.2 (1.31 -13.70) 
 
 
0.018 
TB 
No  
Yes 
 
77 (86.5) 
12 (13.5) 
 
 
11(80.6) 
3 (19.4) 
 
1 (reference group) 
1.75 (0.43-7.19) 
 
 
0.45 
Heart disease 
No  
Yes 
 
  
68 (76.4) 
21 (23.6) 
 
 
4 (50.0) 
7 (50.0) 
 
1 (reference group) 
3.0 (0.96-9.65) 
 
 
0.06 
Patient treatment characteristics 
Antivirals  
  No 
  Yes 
 
62 (69.7) 
27 (30.3) 
 
3 (21.4) 
11 (78.6) 
 
1 (reference group) 
8.4 (2.17-32.6) 
 
 
0.006 
IV steroids 
  No 
  Yes 
   
 
61 (68.5) 
28 (31.5) 
 
5 (35.7) 
9 (64.3) 
 
1 (reference group) 
3.9 (1.2- 12.7) 
 
 
0.02 
Inhaled 
steroids 
  No 
 
69 (77.5) 
20 (22.5) 
 
10 (64.3) 
5 (35.7) 
 
1 (reference group) 
1.9 (0.58 – 6.37) 
 
 
0.3 
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  Yes 
Antibiotics 
  No 
  Yes 
  Missing 
 
0 (0.0) 
14 (100.0) 
0 (0.0) 
 
3 (3.37) 
81 (91.0) 
5 (5.62) 
 
-* 
 
*Unable to calculate OR due to insufficient data  
OR= odds ratio; CI= confidence interval 
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